Healthcare Policy Experts Urge CMS to Quickly Move on Biogen’s Alzheimer’s Drug
The Food and Drug Administration has approved Biogen’s aducanumab drug for Alzheimer’s disease. Several health policy experts are calling for [...]
Biogen’s Newly Approved Alzheimer’s Drug Features a $56K Price Tag
Biogen’s Aduhelm was recently approved by the Food and Drug Administration for use in Alzheimer’s disease. Its $56,000 yearly price [...]
Enthusiastic Parents Daunted by $740,000 Epilepsy Drug Price Tag
Parents of children with a rare type of epilepsy were hopeful when they heard about Ravicti, an FDA-approved drug that [...]
CEVR Leaders Discuss Recent Book on Lowering Prescription Drug Costs
An upcoming webinar will feature drug pricing experts and authors of The Right Price: A Value-Based Prescription for Drug Costs. The [...]
Syneos Health Unveils Patient Voice Consortium to Improve R&D Pipeline
Syneos Health has announced the launch of its Patient Voice Consortium, intended to highlight the patient perspective throughout the drug [...]
Tufts Medical Center and National Health Council Report New Partnership to Enhance Value Assessments
The National Health Council (NHC) and the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts [...]
ISPOR Discussion on Overcoming Cost Barriers to Deliver Novel Gene Therapies
ISPOR recently held a panel discussion on how high gene therapy price tags may limit patient access. New gene therapies, [...]
AmerisourceBergen Interview Highlights the Power of RWE in Drug Development Pipeline
A recent Fierce Biotech interview with AmerisourceBergen research experts focused on the role of real world evidence (RWE) in the [...]
Upcoming Webinar on Successfully Utilizing Data to Improve Patient Outcomes
Each facet of the patient experience generates a substantial amount of data. A webinar will discuss how such data can [...]
FDA Office of Health Equity Leader Discusses Diversity in Clinical Trials
Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) at the FDA RADM [...]
Woman to Woman Podcast Series Highlights Senior HEOR Researcher
Divya Yerraguntla hosts a podcast series that highlights the stories of women who have broken through barriers to succeed in [...]
ICER Reveals Final Evidence Report on Three Multiple Myeloma Therapies
The Institute for Clinical and Economic Review (ICER) has announced a Final Evidence Report evaluating three therapies for use in [...]
Can Improved QALYs Effectively Reduce Drug Prices?
Dan Ollendorf of Tuft’s Center for the Evaluation of Value and Risk in Health (CEVR) shared his thoughts on how [...]
New Article Discusses 35 Oncology Drugs Receiving Accelerated Approval
An article published in the New England Journal of Medicine (NEJM) discusses 35 oncology drugs that received accelerated approval from [...]
ICER Publishes Draft Evidence Report on Alzheimer’s Disease Drug
The Institute for Clinical and Economic Review (ICER) published a Draft Evidence Report regarding Biogen’s aducanumab. The drug is designed to treat [...]
New Report Claims Reducing Drug Prices Will Not Impact Innovation, Discusses HTA Solution
Patients for Affordable Drugs released a report on how lowering drug prices would fail to impact innovation. The authors note [...]
New JMCP Article Discusses Calculating the Price Tag of Gene Therapies
An article published in the Journal of Managed Care & Specialty Pharmacy (JMCP) focuses on the price considerations of new [...]
ICER’s New Whitepaper Features Insight on FDA’s Accelerated Approval Pathway and Proposes Drug Pricing Reform
The Institute for Clinical and Economic Review (ICER) published a whitepaper discussing the Food and Drug Administration’s Accelerated Approval Pathway (AAP). The [...]
Cytel Research Specialist Discusses Benefits of Bayesian Network Models for Clinicians and Clinical Trials
A recent Cytel paper, published in JCO Clinical Cancer Informatics, uses a Bayesian Network Model to accurately predict outcomes in cancer [...]
ISPOR Issue Panels and Workshops Featuring Insight on RWD and Healthcare Outcomes
ISPOR Europe will take place December 1st – 3rd, this year in a virtual format. The Issue Panels and Workshop [...]
Seqster Develops Streamlined Patient Healthcare Platform, Raises $12 Million in Funding
Data aggregator Seqster has raised $12 million in startup funding. The company offers a single platform for EHR (electronic health [...]
Will Patient RWD Improve Cardiovascular Disease Outcomes?
Amgen and Datos Health have partnered to explore how RWD (real world data) can improve outcomes for heart disease patients. Using [...]
HealthVerity Offers Webinar on HEOR and RWD
HealthVerity will offer a webinar on Wednesday, May 5th at 1:00 PM EDT. Speakers will discuss how to effectively use [...]
The Journal of Clinical Pathways Issues Call for Papers
The Journal of Clinical Pathways (JCP) invites you to submit research, quality improvement, and perspectives manuscripts for consideration. Articles detailing [...]
ICER Releases Evidence Report on Lupus Nephritis Drugs
ICER has published a new evidence report on two drugs for use in lupus nephritis patients. FDA-approved voclosporin and belimumab [...]
